PETER EICHWALD: Open Payments
NPI 1992257778 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 107 payments from 11 companies in 2025. Trend: 2023 $1,922 · 2024 $2,429 · 2025 $2,019
Food & beverage: $2,019
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $595 |
| ABBVIE INC. | 34 | $448 |
| LEO Pharma Inc. | 10 | $291 |
| GENZYME CORPORATION | 11 | $226 |
| Incyte Corporation | 8 | $202 |
| Lilly USA, LLC | 6 | $88 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
| Galderma Laboratories, L.P. | 2 | $39 |
| UCB, Inc. | 1 | $18 |
| Organon LLC | 1 | $16 |
Products named: TREMFYA, RINVOQ, DUPIXENT, OPZELURA, ADBRY, SKYRIZI, ANZUPGO, TALTZ.
Industry payments across CA — which companies pay providers there.
